A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
Neuropsychopharmacology – A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
Related Articles
Frontiers | Cognitive assessment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM)
1 Pain and Fatigue Study Center, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States 2 Division of High-Consequence…
Intracerebral haemorrhage — mechanisms, diagnosis and prospects for treatment and prevention
Nature Reviews Neurology – Effective treatments for the acute stages of intracerebral haemorrhage are currently limited. In this Review, the authors consider advances in therapeutic…
Key insights into cannabis‐cancer pathobiology and genotoxicity
Whilst mitochondrial inhibition and micronuclear fragmentation are well established features of the cannabis literature mitochondrial stress and dysfunction has recently been shown to be a…
Cannabis Use Linked to Epigenetic Changes, Cancer Risk – Neuroscience News
Research indicates that cannabis use causes cellular damage that increases the risk of highly cancerous tumors by disrupting mitochondria and damaging DNA.
Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomes
Nature Communications – Some antiseizure medications including valporate are associated with neurodevelopmental conditions in children exposed in utero but evidence is less clear for other…
Snapshots in Neuroscience: Mossy fiber boutons
These images have been selected to showcase the art that neuroscience research can create. As described by Dr. Marta Orlando and colleagues: “This image displays…
Cannabis Compound Found to Improve Sleep – Neuroscience News
Researchers have demonstrated that cannabinol (CBN), a compound found in aged cannabis, improves sleep in rats.
Gatekeepers of the brain: Identifying hidden mechanisms of type A GABA receptor signaling and assembly
Identifying hidden mechanisms of type A GABA receptor signaling and assembly
CNSA White Paper Advocates for Earlier Detection of Alzheimer’s Using Biomarkers – Practical Neurology
Due to the availability of amyloid-reducing therapies, it is critical to use biomarkers to detect Alzheimer disease (AD) in its early stages, accordin
